FDA-filed SPL labeling · retrieved through openFDA

Processed Nerve Allograft

Processed nerve allograft (Avance Nerve Graft) is a surgically implanted nerve scaffold used to treat sensory, mixed, and motor nerve discontinuity — gaps in damaged nerves — in adults and children as young as one month old.

Brand name Avance Nerve Graft

Rx Form 1 Route Soft Tissue

Reviewed by Dr. Brian Staiger, PharmD, BCPS Last reviewed Jul 10, 2026

🧬 Where this information comes from Click to expand

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 1 clinical label set within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →

At a glance

Linked label effectiveJan 23, 2026

AvailabilityRx

Earliest approval/marketing year ⓘ2026

FDA-listed product records ⓘ32

Boxed warningNone found in compared labels

How we combine label and product data →

✓No current FDA shortage listed · checked Sep 21, 2026

⭐ Processed Nerve Allograft at a glance The quick version — the full detail is in the Patient Information Guide below.

💊

HelloPharmacist Editorial Team Bottom Line

Avance Nerve Graft is a surgically implanted scaffold that bridges gaps in damaged nerves, guiding the body's own nerve fibers to regenerate across the defect. It is used for sensory, mixed, and motor nerve discontinuity in patients from one month of age onward. As with any surgical procedure involving donor tissue, there are procedural and infection-related risks your surgeon will discuss with you.

How we write & review this content — our editorial policy →

📖 Processed Nerve Allograft: Patient Information Guide

A plain-language walkthrough of Processed Nerve Allograft — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.

🎯What it's used for▾

Avance Nerve Graft is a processed nerve scaffold implanted surgically to repair gaps in damaged nerves. It is approved for use in adults and children as young as one month old.

Avance Nerve Graft: Sensory nerve discontinuity with gaps of 25 mm or shorter
Avance Nerve Graft: Sensory nerve discontinuity with gaps longer than 25 mm — approved under accelerated approval; continued approval may depend on confirmatory trials
Avance Nerve Graft: Mixed and motor nerve discontinuity — approved under accelerated approval; continued approval may depend on confirmatory trials

⚙️How it works▾

Avance Nerve Graft works as a bridge across a damaged nerve gap. Its preserved internal structure — tiny channels called endoneurial tubes — gives growing nerve fibers a physical path to follow. The inner walls of these channels are lined with proteins (including laminin, collagen, and fibronectin) that send biological signals encouraging nerve cell migration, nerve fiber growth cone interaction, and new nerve fiber extension (neurite outgrowth). The exact mechanism is not fully known, but the bioactive laminin in particular appears important for supporting nerve regeneration.

💊How it's taken▾

Avance Nerve Graft is surgically implanted — it is not taken by mouth or applied at home. The number and size of grafts used depend on the size and number of nerve gaps being repaired, as determined by the surgeon. Each graft is a one-time implant for a single patient.

The graft is thawed in sterile saline or Lactated Ringer's solution for about 6 minutes just before implantation — never heated
Once thawed, the graft must be implanted or discarded within 12 hours
The graft may be trimmed to fit the nerve defect precisely

🤒Side effects — in detail▾

The most common side effects reported with Avance Nerve Graft in clinical studies were mild to moderate and related to the surgical procedure.

Procedural pain (reported in 4% of patients)
Hyperesthesia — heightened or uncomfortable skin sensitivity — at the implant site (3%)
Infection at the implant site
Swelling at the implant site
Adhesions (internal scar tissue bands)
Hypertrophic (thickened, raised) scarring
Impaired motor or sensory function
Neuroma formation (an overgrowth of nerve tissue)

One serious adverse reaction (wound dehiscence — the surgical wound reopening) occurred in a clinical trial. Contact your surgical team right away if your wound opens, you develop signs of infection, or you notice worsening pain or loss of sensation or movement.

⚠️Warnings & precautions▾

Risk of infectious disease transmission: Avance Nerve Graft is made from human donor tissue. Although donors are screened and tested for HIV, hepatitis B and C, syphilis, HTLV-1, and HTLV-2, and screened for CJD, no screening process eliminates all risk. No confirmed cases of viral disease or CJD transmission from Avance have ever been reported. Any suspected infection should be reported to Axogen Corporation at 1-888-296-4361.
Procedural complications: Surgery to implant the graft carries risks including pain, heightened sensitivity, infection, swelling, internal scarring, thickened scars, bleeding, impaired nerve function, and neuroma formation. Anesthesia-related risks also apply. Your surgical team will monitor for these and manage them if they occur.

📋Before taking it▾

Pregnancy: There is no safety data for Avance Nerve Graft use during pregnancy. No animal reproductive studies have been done. Discuss the risks and benefits with your doctor.
Breastfeeding: There is no data on effects on breast milk, the nursing infant, or milk production. Talk to your doctor before proceeding.
Children: Avance Nerve Graft is approved for pediatric patients aged one month and older. Pediatric use is based on extrapolation from adult clinical data.
Older adults (65+): Only a small number of patients 65 and older participated in clinical studies. It is not known whether they respond differently from younger patients.
Because the graft is derived from human donor tissue, patients should be aware of the small but real risk of infectious disease transmission before consenting to surgery.

📦How to store it▾

Store AVANCE at ≤-40°C (≤-40°F) and keep frozen until use.

📄 Written from Processed Nerve Allograft’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →

🩺 Pharmacist Counseling Corner

Quick, plain-English answers to the questions patients ask most about Processed Nerve Allograft — the kind of thing our pharmacy team would talk through with you at the counter.

What exactly is Avance Nerve Graft, and where does it come from? ▾

Avance Nerve Graft is a processed scaffold made from donated human nerve tissue. The donor cells are removed, but the internal structure — tiny tubes that guide nerve fiber regrowth — is kept intact along with key proteins that help nerves regenerate. It's a one-time surgical implant, not a medication you take at home.

What kinds of nerve injuries is it used for? ▾

Avance is used to bridge gaps in damaged peripheral nerves — the nerves outside the brain and spinal cord. That includes sensory nerves (which carry feeling), as well as mixed and motor nerves (which also control muscle movement). It can be used in both adults and children as young as one month old.

What side effects should I watch for after the procedure? ▾

The most commonly reported side effects were post-surgical pain and heightened skin sensitivity at the site. Other things to watch for include signs of infection (redness, warmth, discharge, fever), wound reopening, swelling, or changes in feeling or movement in the affected area. Call your surgeon right away if any of those happen — don't wait for your next appointment.

Is there any risk from the graft being made from human tissue? ▾

There is a small, theoretical risk of infectious disease transmission since the graft comes from donated human tissue. Donors are carefully screened and tested for infections like HIV and hepatitis, but no screening is 100% perfect. That said, no case of viral disease or CJD transmission from Avance has ever been confirmed. Your surgeon will go over this risk with you before the procedure.

Can Avance Nerve Graft be used if I'm pregnant or breastfeeding? ▾

There's currently no safety data on using Avance Nerve Graft during pregnancy or while breastfeeding. This doesn't mean it's definitely unsafe, but it does mean you and your doctor need to weigh the risks and benefits carefully before going ahead. Make sure your surgeon knows your situation.

How will I know if the nerve graft is working? ▾

Nerve regeneration is a slow process — recovery of sensation or movement can take months. In clinical studies, improvement was measured using a test called static two-point discrimination, which checks how well you can feel two close points of touch. Your surgical team will monitor your progress over time. Follow all your scheduled follow-up appointments so they can track how well your nerve is healing.

Is Processed Nerve Allograft available over the counter? ▾

Processed Nerve Allograft is dispensed by prescription according to its FDA labeling, so it isn't sold over the counter. Your prescriber and pharmacist will determine if it's appropriate for you.

When was Processed Nerve Allograft first available? ▾

Processed Nerve Allograft has been available in the United States since at least 2026, based on FDA approval history (Drugs@FDA) and product marketing records.

Who makes Processed Nerve Allograft? ▾

Processed Nerve Allograft is supplied by 2 manufacturers listed in the FDA NDC Directory, including Axogen Corporation, Isomedix Operations Inc.

💬 Answers drafted from Processed Nerve Allograft’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →

🧰 Keep exploring

🌿Drug & Supplement CheckerProcessed Nerve Allograft vs. vitamins & herbs 💬Ask a PharmacistFree answer, usually < 24h 🔎NDC & pricing lookupFind Processed Nerve Allograft NDCs & costs 🅰️Browse Drugs A–ZLook up any medication

📊 Detailed data & references for Processed Nerve Allograft Forms & strengths, pricing, billing codes, manufacturers, safety reports and sourcing — the data behind the page. Most people can stop here.

💊 How Processed Nerve Allograft comes

Processed Nerve Allograft is available in 1 form. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Insert or device

By mouth · Soft Tissue

Brands Avance Nerve Graft

How this form is used

What it may be used for

Avance Nerve Graft is used to repair sensory nerve gaps of 25 mm or shorter in adults and children aged one month and older
Avance Nerve Graft is used to repair sensory nerve gaps longer than 25 mm in adults and children aged one month and older (accelerated approval)
Avance Nerve Graft is used to repair mixed and motor nerve discontinuity in adults and children aged one month and older (accelerated approval)

Important instructions

Avance Nerve Graft is thawed in sterile normal saline or Lactated Ringer's solution for approximately 6 minutes immediately before surgical use — it must not be heated
Avance Nerve Graft must be implanted or discarded within 12 hours of thawing
Avance Nerve Graft is available in 16 size combinations; the surgeon selects the length and diameter that best matches the nerve gap to be repaired
Avance Nerve Graft may be trimmed to fit the defect, and each graft is intended for a single patient only

Available strengths 16 strengths

HUMAN PERIPHERAL NERVE TISSUE 1 mm/15mm HUMAN PERIPHERAL NERVE TISSUE 1 mm/30mm HUMAN PERIPHERAL NERVE TISSUE 1 mm/50mm HUMAN PERIPHERAL NERVE TISSUE 1 mm/70mm HUMAN PERIPHERAL NERVE TISSUE 2 mm/15mm HUMAN PERIPHERAL NERVE TISSUE 2 mm/30mm

Show 10 more strengths Show fewer strengths

HUMAN PERIPHERAL NERVE TISSUE 2 mm/50mm HUMAN PERIPHERAL NERVE TISSUE 2 mm/70mm HUMAN PERIPHERAL NERVE TISSUE 3 mm/15mm HUMAN PERIPHERAL NERVE TISSUE 3 mm/30mm HUMAN PERIPHERAL NERVE TISSUE 3 mm/50mm HUMAN PERIPHERAL NERVE TISSUE 3 mm/70mm HUMAN PERIPHERAL NERVE TISSUE 4 mm/15mm HUMAN PERIPHERAL NERVE TISSUE 4 mm/30mm HUMAN PERIPHERAL NERVE TISSUE 4 mm/50mm HUMAN PERIPHERAL NERVE TISSUE 4 mm/70mm

📊 Processed Nerve Allograft across the U.S. market

How Processed Nerve Allograft appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

Dose forms ⓘ

Manufacturers

Brand names

FDA-listed product records ⓘ

2026

First marketed ⓘ

2makers

Axogen Corporation50%

Isomedix Operations Inc50%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

🔍 Compare Processed Nerve Allograft products

A representative set of FDA-listed product records for Processed Nerve Allograft — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Strength	Route	Manufacturer / Labeler	Category ⓘ	Details
💊Insert or device
HUMAN PERIPHERAL NERVE TISSUE 1 mm/15mm	Soft Tissue	Axogen Corporation	BLA	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 1 mm/30mm	Soft Tissue	Axogen Corporation	BLA	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 1 mm/50mm	Soft Tissue	Axogen Corporation	BLA	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 1 mm/70mm	Soft Tissue	Axogen Corporation	BLA	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 2 mm/15mm	Soft Tissue	Axogen Corporation	BLA	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 2 mm/30mm	Soft Tissue	Axogen Corporation	BLA	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 2 mm/50mm	Soft Tissue	Axogen Corporation	BLA	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 2 mm/70mm	Soft Tissue	Axogen Corporation	BLA	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 3 mm/15mm	Soft Tissue	Axogen Corporation	BLA	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 3 mm/30mm	Soft Tissue	Axogen Corporation	BLA	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 3 mm/50mm	Soft Tissue	Axogen Corporation	BLA	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 3 mm/70mm	Soft Tissue	Axogen Corporation	BLA	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 4 mm/15mm	Soft Tissue	Axogen Corporation	BLA	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 4 mm/30mm	Soft Tissue	Axogen Corporation	BLA	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 4 mm/50mm	Soft Tissue	Axogen Corporation	BLA	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 4 mm/70mm	Soft Tissue	Axogen Corporation	BLA	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 1 mm/15mm	—	Isomedix Operations Inc	DRUG FOR FURTHER PROCESSING	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 1 mm/30mm	—	Isomedix Operations Inc	DRUG FOR FURTHER PROCESSING	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 1 mm/50mm	—	Isomedix Operations Inc	DRUG FOR FURTHER PROCESSING	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 1 mm/70mm	—	Isomedix Operations Inc	DRUG FOR FURTHER PROCESSING	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 2 mm/15mm	—	Isomedix Operations Inc	DRUG FOR FURTHER PROCESSING	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 2 mm/30mm	—	Isomedix Operations Inc	DRUG FOR FURTHER PROCESSING	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 2 mm/50mm	—	Isomedix Operations Inc	DRUG FOR FURTHER PROCESSING	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 2 mm/70mm	—	Isomedix Operations Inc	DRUG FOR FURTHER PROCESSING	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 3 mm/15mm	—	Isomedix Operations Inc	DRUG FOR FURTHER PROCESSING	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 3 mm/30mm	—	Isomedix Operations Inc	DRUG FOR FURTHER PROCESSING	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 3 mm/50mm	—	Isomedix Operations Inc	DRUG FOR FURTHER PROCESSING	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 3 mm/70mm	—	Isomedix Operations Inc	DRUG FOR FURTHER PROCESSING	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 4 mm/15mm	—	Isomedix Operations Inc	DRUG FOR FURTHER PROCESSING	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 4 mm/30mm	—	Isomedix Operations Inc	DRUG FOR FURTHER PROCESSING	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 4 mm/50mm	—	Isomedix Operations Inc	DRUG FOR FURTHER PROCESSING	View NDC →
HUMAN PERIPHERAL NERVE TISSUE 4 mm/70mm	—	Isomedix Operations Inc	DRUG FOR FURTHER PROCESSING	View NDC →

Showing 32 of 32 products — FDA National Drug Code Directory. See every product, package size and price: browse all 32 Processed Nerve Allograft NDCs →

🏷️ Sold under these brand names

Avance Nerve Graft

🏭 Manufacturers & labelers

Axogen Corporation 16 Isomedix Operations Inc 16

nerve allograft: A nerve graft taken from a human donor (rather than the patient's own body) and processed for transplant use.

acellular: Having had its living cells removed, leaving only the structural framework of the original tissue.

nerve scaffold: A supportive structure that guides the regrowth of nerve fibers across a gap or injury.

nerve discontinuity: A gap or break in a nerve, meaning the two ends are no longer connected.

endoneurial tubes: Tiny channel-like structures inside a nerve that guide individual nerve fibers and provide a path for regeneration.

axonal regeneration: The process by which damaged nerve fibers (axons) regrow and reconnect after an injury.

laminin: A protein found in nerve tissue that plays a key role in helping nerve cells migrate and new nerve fibers grow.

fibronectin: A protein in the tissue scaffold that helps cells attach and move during healing and regeneration.

proteoglycans: Large molecules in tissue that help organize the structural environment and support cell communication.

Schwann cell: A type of support cell in the peripheral nervous system that helps nerve fibers grow and function.

neurite extension: The process of a nerve cell growing a new projection or fiber outward, which is a key step in nerve repair.

hyperesthesia: Increased or abnormal sensitivity to touch or other sensations, which can feel uncomfortable or painful.

neuroma: An abnormal overgrowth of nerve tissue that can form after a nerve injury, sometimes causing pain.

adhesions: Bands of internal scar tissue that can form after surgery, sometimes causing tissues to stick together.

hypertrophic scar: A raised, thickened scar that forms at the site of a wound or incision.

coaptation: The surgical joining of two nerve ends, often using sutures, to allow them to reconnect and heal.

epineurium: The tough outer sheath that surrounds and protects a peripheral nerve.

wound dehiscence: A complication where a surgical wound splits open or fails to heal properly.

accelerated approval: An FDA pathway that allows approval of a drug or device for a serious condition based on early data that is expected to predict clinical benefit, while a confirmatory study is completed.

static two-point discrimination (s2PD): A clinical test that measures how well a person can feel two separate points of touch that are close together — used to assess nerve recovery.

peripheral nerve: Nerves located outside the brain and spinal cord that carry signals between the body and the central nervous system.

motor nerve: A nerve that carries signals from the brain to muscles, controlling movement.

sensory nerve: A nerve that carries signals such as touch, pain, and temperature from the body to the brain.

mixed nerve: A nerve that contains both sensory and motor fibers, handling both feeling and movement.

Creutzfeldt-Jakob disease (CJD): A rare and serious brain disorder caused by abnormally folded proteins (prions); a theoretical risk associated with use of human tissue products.

variant Creutzfeldt-Jakob disease (vCJD): A form of CJD linked to exposure to a similar disease in cattle; screened for, though not confirmed to have been transmitted by Avance.

cadaveric donor: A person who has died and donated their tissues or organs for medical use.

HTLV-1 / HTLV-2: Human T-cell Leukemia-lymphoma viruses; rare viruses tested for in some donor screening programs.

confirmatory clinical trial: A follow-up study required after accelerated approval to verify that a treatment truly provides the expected benefit.

fascicles: Bundles of nerve fibers grouped together within a nerve.

extrapolation: Applying findings from one group (such as adults) to another (such as children) based on similar biology and expected responses.

pharmacodynamics: The study of what a drug or device does to the body and how it produces its effects.

pharmacokinetics: The study of how the body absorbs, distributes, metabolizes, and eliminates a drug or substance.

in vitro: Tested in a laboratory setting (for example, in cells or test tubes) rather than in a living organism.

adverse reaction: An unwanted or harmful effect that a medicine causes in the body.

Adverse Reactions: Unwanted or harmful effects that people experienced while taking a medicine, listed on its official label.

Clinical Studies: The label section summarizing the research trials used to show that a medicine works and is acceptably safe.

Dosage and Administration: The label section explaining how much of a medicine to use and how to take or give it.

hepatitis: Inflammation of the liver, which can be caused by infections, alcohol, or certain medicines.

incidence: How often a new event, such as a side effect, happens in a group of people over a set period of time.

Indications and Usage: The label section stating which medical conditions the FDA has officially approved the medicine to treat, prevent, or manage.

NDC: A unique number that identifies a specific medicine, its maker, strength, and package size.

nursing infant: A baby who is being fed breast milk.

Warnings and Precautions: The label section describing serious risks to know about and safety steps to follow while using a medicine.

🔬 Where this comes from

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄

FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. ✓ Linked label effective Jan 23, 2026

🏭

Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Processed Nerve Allograft.

📈

Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.

🚨

Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

🧾 Clinical label set — FDA-filed SPL labels retained for Processed Nerve Allograft after exact ingredient or ingredient-combination matching and applicable route/form matching

Clinical labels in scope: 1
NDC products indexed: 32
Distinct labelers/manufacturers represented: 2
Linked representative label ⓘ: Axogen Corporation
Linked label effective: Jan 23, 2026
Composite sections available: 20
Linked SPL Set ID: e50d90fa-83ef-4d1b-9691-2b9c7bbdc2ae
Linked SPL Document ID: 5c0c36c2-0dcf-4762-8653-31805880f668

Open the linked representative label on DailyMed ↗

How we combine label and product data

HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 1 FDA-filed SPL label set within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.

For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Axogen Corporation is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.

This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.

Processed Nerve Allograft

📖 Processed Nerve Allograft: Patient Information Guide

🩺 Pharmacist Counseling Corner

🧰 Keep exploring

💊 How Processed Nerve Allograft comes

Insert or device

📊 Processed Nerve Allograft across the U.S. market

🔍 Compare Processed Nerve Allograft products

📈 What people report — real-world data (FDA FAERS)

🏛️ The road to your pharmacy

🚨 Recall history

📦 Supply & shortage status

🏷️ Sold under these brand names

🏭 Manufacturers & labelers

🔬 Where this comes from

How we combine label and product data

Processed Nerve Allograft

📖 Processed Nerve Allograft: Patient Information Guide

🩺 Pharmacist Counseling Corner

🧰 Keep exploring

💊 How Processed Nerve Allograft comes

📊 Processed Nerve Allograft across the U.S. market

🔍 Compare Processed Nerve Allograft products

📈 What people report — real-world data (FDA FAERS)

🏛️ The road to your pharmacy

🚨 Recall history

📦 Supply & shortage status

🏷️ Sold under these brand names

🏭 Manufacturers & labelers

🔬 Where this comes from

How we combine label and product data

🔗 Related medications